OKC pharma firm acquired in deal valued up to $665 million

By admin | News | 0 comment | 22 November, 2016 | 0

OKC pharmaceutical firm acquired in deal valued up to $665 million
By Don Mecoy
Copyright © 2016, The Oklahoma Publishing Company

Some Oklahoma angel investors are getting their wings.

Those “angels,” a term for individual investors in early stage companies, will get payoffs ranging from about five times to about 20 times what they risked in the development of Oklahoma City-based Selexys Pharmaceuticals Corp.

Selexys has closed a deal to sell the company for up to $665 million to global drug giant Novartis.

Former Selexys CEO Scott Rollins said all the early investments in the company came from Oklahomans and state-based entities.

“It’s been a great story,” Rollins said Monday. “They’re all going to make a lot of money.”

Read the story at NewsOK.com.

i2E, Novartis, Presbyterian Health Foundation, Scott Meacham, Scott Rollins, Selexys, Selexys Pharmaceuticals, Tetherex, University of Oklahoma

Dia ‘living her dream’ by helping other people achieve theirs

By sarah | Comments are Closed

By Scott Meacham Srijita Dia Ghosh is living her dream of helping other people achieve theirs. Srijita Dia Ghosh, i2E’s newest venture advisor, was born and brought up in West Bengal, India. Her home cityRead more
The science to brewing beer highlighted by OKBio BrewFest

By sarah | Comments are Closed

By Scott Meacham There is a real science to brewing beer, and there is real chemistry in the annual OKBio BrewFest returning to Chickasaw Bricktown Ballpark October 21 from 5:00 to 7:00 p.m. BrewFest showcasesRead more
A renewed admiration for the entrepreneurs

By sarah | 0 comment

By Scott Meacham Success of Oklahoma ventures has given me renewed admiration for the entrepreneurs who built those companies. We have had multiple successful portfolio exits in recent years — including Selexys, WeGoLook, and AlkamiRead more
Oklahoma Innovation Model working at its best with SNT acquisition

By sarah | Comments are Closed

By Scott Meacham The acquisition of Spiers New Technologies is the Oklahoma Innovation Model working at its very best. At i2E, we are in the business of commercializing new technologies. It’s exciting work, especially whenRead more
MaxQ turns ‘the worst thing that happens’ into opportunity

By sarah | Comments are Closed

By Scott Meacham The worst thing that happens to you may be the best thing for you. There is a quote attributed to humorist and philosopher Will Rogers that fits the experiences of the pastRead more

Cancel reply

You must be logged in to post a comment.

Next Previous

OKC pharma firm acquired in deal valued up to $665 million

OKC pharma firm acquired in deal valued up to $665 million

Related Post

Dia ‘living her dream’ by helping other people achieve theirs

The science to brewing beer highlighted by OKBio BrewFest

A renewed admiration for the entrepreneurs

Oklahoma Innovation Model working at its best with SNT acquisition

MaxQ turns ‘the worst thing that happens’ into opportunity

Leave a Comment

Cancel reply

Oklahoma City Office

Tulsa Office